At midnight on New Year’s Eve, some people watch a ball drop. At Capital Rx, staff have described watching prescription claims arrive. They guess the first drug and the first state. Somewhere, a pharmacist is filling a prescription; somewhere else, a new benefit plan is discovering whether its promises survive contact with a computer. It is an unusually revealing office ritual. This company’s grand idea depends on getting very ordinary transactions right.
- Change the incentive: earn a disclosed administration fee, pass through rebates.
- Own the machinery: build Judi to run the benefit, then license it.
- Follow the expansion: Capital Rx is now Judi Rx, inside Judi Health.
The name requires a little housekeeping. Capital Rx adopted Judi Health as its umbrella brand in September 2025. The pharmacy benefit manager kept its old name until July 15, 2026, when it became Judi Rx. Judi Care covers medical, dental and vision administration; Judi Cloud licenses the underlying technology. The original business has grown a set of siblings.
The fee changes the assignment
A pharmacy benefit manager sits between a health plan, drug manufacturers and pharmacies. It processes prescriptions, helps decide which medicines a plan covers, negotiates arrangements and supports members. The employer buys administration. The employee encounters the result at the counter, often while wondering why something that worked last month suddenly needs permission.
Capital Rx’s proposition starts with the money. Its PBM says it earns a flat administrative fee per claim, retains no manufacturer rebates and takes no spread between what it charges the plan and pays the pharmacy. Its pricing uses National Average Drug Acquisition Cost, or NADAC, a federally published benchmark based on pharmacy acquisition data. The attraction is an outside reference a buyer can inspect.
“We don’t make money when you spend more money,” says the Judi Rx product page. More precisely, the fee is detached from a medicine’s price; the number of claims still matters. This distinction gives the pitch some useful discipline. Transparent describes an arrangement you can examine. It does not calculate your savings for you.
The first obstacle was underneath
Founded in late 2017, Capital Rx emerged from years of pharmacy procurement, audit and software experience. AJ Loiacono and founding technology chief Ryan Kelly thought there was an opening in the industry’s financial incentives. Then they investigated how to operate their preferred model.
Kelly’s account on the company’s Astonishing Healthcare podcast describes the discovery: existing administration technology was too inefficient for what they wanted to do. The initial assignment expanded. They would need to build a platform themselves. Judi, short for adjudication, launched in 2021. A drug-pricing business had acquired a substantial software construction project.
That choice helps explain the company’s position. Judi combines work that otherwise passes between systems: benefit configuration, eligibility, claims processing, reporting and billing. APIs let other software connect. Health plans and third-party administrators can license the platform rather than purchase the full PBM service. Capital Rx became both a benefits operator and a supplier of the machinery behind one.
Expensive plumbing, patient capital
Building enterprise software while administering benefits takes money. Capital Rx raised $106 million in a June 2022 Series C led by B Capital. In October 2023, a strategic investment exceeded $50 million, bringing in health systems including Inova, Novant Health and Memorial Hermann alongside Transformation Capital. Hospitals were helping finance a business intended to make benefits administration less cumbersome.
Broader investment announcement
The September 2025 announcement was larger: $400 million in investment, including a $252 million Series F, led by Wellington Management and General Catalyst. Those figures describe overlapping financing. They should never become a $652 million headline. They also do not reveal exactly what Judi cost to build. Forbes reported a $3.25 billion valuation at the time.
Customers buy several different things here. A self-funded employer wants prescription coverage and service. A union needs benefits to function for its members. A health plan may want software it can operate under its own arrangements. In January 2026, the company reported more than five million contracted employer PBM lives, with new partnerships including 13 Fortune 500 corporations and 21 hospital groups or health systems. Contracted business and implemented enrollment are different measures.
Beyond the pharmacy counter
The broader ambition became tangible in June 2025, when Capital Rx acquired Amino Health. Its navigation tools help members find care, extending the business beyond paying a prescription claim. Putting medical and pharmacy administration together could also give a plan a more complete view of a member’s care. That is a useful operational proposition, provided the information actually arrives and supports action.
“Once you see the medical and pharmacy claims coming in at the same time, you never want to go back.”
AJ Loiacono, speaking to Forbes, September 2025
The expansion continues through partners. In September 2026, Judi Health added Color Health, WellTheory and Cylinder to its clinical ecosystem. It also announced StarkRx with Employers Health, a modular pharmacy benefits offering. These are ways to package administration and specialized care around the platform, rather than expect one company to deliver every service itself.
Ask to see the whole bill
The competition includes CVS Caremark, Express Scripts and Optum Rx, as well as transparent-model alternatives such as Navitus and SmithRx. Capital Rx’s distinctive combination is its disclosed PBM economics and proprietary administration software. Neither element exempts it from the practical test: can this particular plan get appropriate coverage, reliable service and a better total cost?
A buyer can copy the questions. What is the administrative fee? Who keeps rebates? Can the plan inspect claim-level payments? Which pharmacies and medicines are covered? What must be migrated? Compare the net bill, including service fees, against the needs of the actual population. Specialty utilization, benefit design and member disruption can outweigh an attractive pricing formula.
The midnight ritual supplies the final test. A clean contract needs a functioning claim, a reachable support team and a member who can collect a medicine. Capital Rx’s wager is that better incentives become useful when the infrastructure can carry them all the way to the counter.